Search alternatives:
nm decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
w decrease » we decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
5 w » 5 wt (Expand Search)
Showing 441 - 460 results of 64,358 for search '(( 5 ((((nm decrease) OR (nn decrease))) OR (a decrease)) ) OR ( 5 w decrease ))', query time: 0.92s Refine Results
  1. 441
    Amplitude for A/L = 0.02.

    Amplitude for A/L = 0.02. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
    Save to List
    Saved in:
  2. 442
    Amplitude for A/L = 0.03.

    Amplitude for A/L = 0.03. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
    Save to List
    Saved in:
  3. 443
    Supplemental Figure 1 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Figure 1 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  4. 444
    Supplemental Figure 7 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Figure 7 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  5. 445
    Supplemental Figure 2 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Figure 2 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  6. 446
    Supplemental Table 1 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Table 1 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  7. 447
    Supplemental Figure 6 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Figure 6 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  8. 448
    Supplemental Figure 4 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Figure 4 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  9. 449
    Supplemental Figure 8 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Figure 8 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  10. 450
    Supplemental Figure 3 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Figure 3 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  11. 451
    Supplemental Figure 9 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume

    Supplemental Figure 9 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

    Published 2023
    Save to List
    Saved in:
  12. 452
    Proposed treatment algorithm for 5-FU (Fluorouracil) coronary vasospasm patients.

    Proposed treatment algorithm for 5-FU (Fluorouracil) coronary vasospasm patients. by Amna Zafar (12369151)

    Published 2022
    Save to List
    Saved in:
  13. 453
    Schematic presentation <i>M</i>. <i>bovis</i> PG45 5′ nucleotidase and phylogenetic tree of its homologs.

    Schematic presentation <i>M</i>. <i>bovis</i> PG45 5′ nucleotidase and phylogenetic tree of its homologs. by Aga E. Gelgie (17661720)

    Published 2024
    Save to List
    Saved in:
  14. 454
    Latent growth curve model estimating the change in moderate-to-vigorous physical activity (MVPA) from follow-up surveys W1 to W3.

    Latent growth curve model estimating the change in moderate-to-vigorous physical activity (MVPA) from follow-up surveys W1 to W3. by Glen E. Duncan (9238792)

    Published 2021
    Save to List
    Saved in:
  15. 455
    EHD2 siRNA treated HUVEC showed decreased NO generation and cytosolic Ca<sup>2+</sup> response.

    EHD2 siRNA treated HUVEC showed decreased NO generation and cytosolic Ca<sup>2+</sup> response. by Claudia Matthaeus (7485782)

    Published 2019
    Save to List
    Saved in:
  16. 456
    Baseline characteristics of all patients with vasospasm, and comparison of those of who continued 5-FU therapy with cardiac pre-treatment vs. those who stopped 5-FU therapy.

    Baseline characteristics of all patients with vasospasm, and comparison of those of who continued 5-FU therapy with cardiac pre-treatment vs. those who stopped 5-FU therapy. by Amna Zafar (12369151)

    Published 2022
    Save to List
    Saved in:
  17. 457
    Fibrosis and TUNEL staining.

    Fibrosis and TUNEL staining. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:
  18. 458
    Fibrosis markers.

    Fibrosis markers. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:
  19. 459
    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR.

    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:
  20. 460
    Immunoblotting for JAK, STAT, and SMAD.

    Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:

Search Tools: